Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative Bioavailability of Roxadustat Formulations
NCT03960489Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of roxadustat in anemia of chronic kidney disease (CKD-A) (4 arms), sponsored by Astellas Pharma. Primary endpoints: Area Under the Curve From Time of Dosing Extrapolated to Time Infinity, Area Under the Concentration-Time Curve From the Time of Dosing to Last Measurable Concentration and 1 more. Started Jul 2019; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT03960489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03960489.